Levipil 750 Tablet contains Levetiracetam 750 mg, an antiepileptic medication primarily used to manage partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby stabilizing neuronal activity and preventing seizure propagation. This medication is indicated as adjunctive therapy in adults and children aged 4 years and above. Levipil 750 Tablet is well-absorbed orally, with rapid onset of action and minimal drug interactions, making it a preferred choice in epilepsy management. Common side effects include somnolence, dizziness, headache, and fatigue, which are generally mild and transient. It is essential to adhere to the prescribed dosage and not discontinue therapy abruptly to avoid seizure exacerbation. Caution is advised in patients with renal impairment, and dosage adjustments may be necessary. Levipil should be used under medical supervision, with regular monitoring for efficacy and adverse effects. Pregnant or breastfeeding women should consult their healthcare provider before use. Overall, Levipil 750 Tablet offers effective seizure control with a favorable safety profile, improving quality of life for individuals with epilepsy.